Category:
Biological and Medicinal Chemistry
,
Working Paper
, Title:
New insights in the mechanism of the SARS-CoV-2 Mpro inhibition by benzisoselenazolones and diselenides
, Authors:
Luca Sancineto, Francesca Mangiavacchi, Agnieszka Dąbrowska, Agata Pacuła, Magdalena Obieziurska-Fabisiak, Veronica Ceccucci, Cecilia Scimmi, Juan Kong, Yao Zhao, Gianluca Ciancaleoni, Vanessa Nascimento, Bruno Rizzuti, Anna Kula-Pacurar, Haitao Yang, Jacek Ścianowski, Ying Lei, Krzysztof Pyrc, Claudio Santi
Version 2 posted 12 March 2024
Extract found to contain search terms
Jin, Z. et al. Structure of Mpro from COVID -19 virus and discovery of its inhibitors. bioRxiv 2020.02.26.964882 (2020) doi:10.1101/2020.02.26.964882. 5. Nadeem, M. S. et al. Origin, Potential Therapeutic Targets and Treatment for Coronavirus Disease (COVID -19). Pathogens 9 , 307 (2020). 6. Harrison, C. Drug researchers pursue new lines of attack against COVID -19. Nat. Biotechnol. 38, 659–662 (2020). 7. Ghahremanpour, M. M. et al. Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2. ACS Med. Chem. Lett. 11, 2526–2533 (2020). 8. Parnham, M. J. & Sies, H. The early research and development of ebselen. Biochem. Pharmacol. 86, 1248–1253 (2013). 9877
Downloads